Updated systematic review and meta-analysis of extended adjuvant temozolomide in patients with newly diagnosed glioblastoma.

Tejpal GuptaJeevi Mona Priyadharshni SelvarajanSadhana KannanNandini MenonArchya DasguptaAbhishek Chatterjee

Published in: Neuro-oncology advances (2023)

Apparent survival benefit of extended adjuvant TMZ in newly diagnosed GBM is largely driven by nonrandomized comparative studies with high inherent potential for multiple biases.

Keyphrases

newly diagnosed
early stage
case control
human health
risk assessment
climate change